Document is current
Any future updates will be listed below
-
Authors
Ndoye, Tidiane
Majeres Lugand, Maud
Diallo, Abdoulaye Moussa
Sakho, Seynabou
Pouye, Mouhamadou Moustapha
Dieng, Kadidiatou
Faye, Sylvain Landry B.
-
Funding
Funding for this research was provided by:
MMV Medicines for Malaria Venture
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 23 October 2025
First Online: 25 November 2025
Declarations
:
: Ethical approval was obtained from the national ethics committees of Senegal—Comité National d’Ethique pour la Recherche en Santé (CNERS) Protocol SEN23/76, numéro 292 MSAS/CNERS/SP. In addition, preliminary meetings were held with the National Malaria Control Programme, district health authorities and the chiefs of the concerned localities to present the content of the survey, obtain their commitment and assistance, and ensure data collection in the field. All participants provided written consent for use of their de-identified contributions.
: MML is an employee of MMV Medicines for Malaria Venture. TN, AMD, SS, MMP, KD and SLBF declare no competing interests.
